Search results for "Kidney disease"

showing 10 items of 457 documents

Chronic kidney disease and dialysis therapy: incidence and prevalence in the world

2021

Сhronic kidney disease (CKD) is the important public and medical problem in the world because of a large burden on health care systems. The prevalence of CKD and number of dialysis patients are increasing in the world. The prevalence and incidence of CKD depends on age, race, and gender of patients, region, and the presence of the CKD registry in a country. Diabetes mellitus (DM) and arterial hypertension (AH) are the most common causes of end stage renal disease (ESRD). It is projected that the number of dialysis patients will reach 5.5 million in 2030. Specific strategies and interventions should be urgently aimed at reducing in the burden of CKD by means of the prevention, detection and …

medicine.medical_specialtyDialysis Therapyhemodialysisbusiness.industryIncidence (epidemiology)030232 urology & nephrologyPharmaceutical SciencePharmacymedicine.diseaseurologic and male genital diseasesfemale genital diseases and pregnancy complicationsRS1-44103 medical and health sciences0302 clinical medicinePharmacy and materia medicaperitoneal dialysisInternal medicinemedicinePharmacology (medical)030212 general & internal medicinebusinesschronic kidney diseaseKidney diseaseFarmatsija
researchProduct

Review of the renal endpoints used in cardiovascular safety clinical trials in type 2 diabetes mellitus patients and their importance in primary care.

2019

Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes mellitus (T2DM). Furthermore, CKD confers a considerable increase in the risk of cardiovascular (CV) morbidity and mortality. In line with the need to improve knowledge in this field, this article aims to describe the renal endpoints used in the different cardiovascular outcome trials (CVOTs). The objective is to better know the renal variables used in the different CVOTs in order to optimize the implementation of advances in the prevention of progressive diabetic kidney disease in patients with T2DM in clinical practice.

medicine.medical_specialtyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismDiseasePrimary careType 2 diabetesurologic and male genital diseasesGlobal HealthDiabetic nephropathy03 medical and health sciences0302 clinical medicineRisk FactorsDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsDiabetic Nephropathies030212 general & internal medicineIntensive care medicineNutrition and DieteticsPrimary Health Carebusiness.industryType 2 Diabetes Mellitusmedicine.diseaseClinical trialSurvival RateDiabetes Mellitus Type 2Cardiovascular DiseasesMorbidityFamily PracticebusinessKidney diseasePrimary care diabetes
researchProduct

Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentri…

2021

Control of dyslipidemia in chronic kidney disease (CKD) is not always guaranteed with statins and/or ezetimibe. Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) have opened up a new era in lipid control, but their effect on renal function and proteinuria in real life have not yet been evaluated. The aim of the present study was to analyze the evolution of renal function and proteinuria in a cohort of CKD patients treated with PCSK9i. This retrospective multicentric cohort study included CKD patients treated with PCSK9i. Baseline epidemiological data, comorbidities and laboratory findings (including estimated glomerular filtration rate [eGFR], proteinuria and lipid profile) …

medicine.medical_specialtyEndocrinology Diabetes and MetabolismUrologyRenal functionurologic and male genital diseasesMicrobiologyBiochemistryArticleNephrotoxicitychemistry.chemical_compoundEzetimibePCSK9iCKDmedicinekidney functionMolecular BiologyCreatinineProteinuriamedicine.diagnostic_testbusiness.industrymedicine.diseaseQR1-502female genital diseases and pregnancy complicationschemistryInsuficiència renal crònicaproteinuriamedicine.symptomLipid profilebusinessDyslipidemiaKidney diseasemedicine.drugMetabolites
researchProduct

Wine consumption and renal diseases: new perspectives.

2006

Investigations into the relation between wine consumption and kidney disease have been limited. Patients with chronic renal failure show accelerated atherosclerotic damage and, considering the well-known protective effect of wine on the cardiovascular system, moderate wine consumption might be advantageous. Oxidative stress and endothelial dysfunction, which are inter-related, play a role in the pathophysiology of many renal diseases, including acute and chronic renal failure. Ethanol and non-alcoholic wine components, especially polyphenols, influence oxidative balance and endothelial function. Although long-term alcohol abuse has been associated with many renal alterations in humans, in e…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismWinePharmacologyKidneyAntioxidantsNephropathyDiabetic nephropathyPhenolsInternal medicinemedicineHumansEndothelial dysfunctionFlavonoidsWineKidneyNutrition and DieteticsRenal ischemiabusiness.industryPolyphenolsfood and beveragesKidney metabolismmedicine.diseaseOxidative Stressmedicine.anatomical_structureEndocrinologyKidney Failure ChronicEndothelium VascularbusinessOxidation-ReductionKidney disease
researchProduct

Chronic Kidney Disease, Diabetes, and Risk of Mortality After Acute Myocardial Infarction: Insight From the FAST-MI Program

2020

Diabetes is associated with a substantially increased risk of all-cause death, mainly driven by cardiovascular (CV) mortality. Furthermore, diabetes is associated with poorer outcomes after acute myocardial infarction (AMI) (1). Impaired glomerular filtration rate (GFR) is also associated with an increased risk of CV mortality (2). However, whether diabetes still confers a higher risk of mortality in patients with impaired GFR remains unknown. The aim of this study was to assess the long-term prognostic significance of both diabetes and renal impairment in two prospective nationwide cohorts of AMI patients: FAST-MI (French Registry of Acute ST-Elevation or non-ST-elevation Myocardial Infarc…

medicine.medical_specialtyEndocrinology Diabetes and Metabolism[SDV]Life Sciences [q-bio]Renal function030209 endocrinology & metabolism03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitusIntensive careInternal MedicinemedicineRisk of mortality030212 general & internal medicineMyocardial infarction10. No inequalityComputingMilieux_MISCELLANEOUSAdvanced and Specialized NursingFramingham Risk Scorebusiness.industrymedicine.disease3. Good healthHeart failureCardiologybusinessKidney disease
researchProduct

Sodium-Lithium Countertransport in Autosomal Polycystic Kidney Disease

1997

medicine.medical_specialtyEndocrinologybusiness.industryInternal medicinePolycystic kidney diseaseMedicineSodium lithium countertransportbusinessmedicine.disease
researchProduct

Role of Renin-Angiotensin-Aldosterone System and of Sympathetic Activity in Arterial Hypertension Associated with Autosomal Dominant Polycystic Kidne…

1997

medicine.medical_specialtyEndocrinologybusiness.industryInternal medicineRenin–angiotensin systemAutosomal dominant polycystic kidney diseaseMedicineSympathetic activitybusinessmedicine.disease
researchProduct

Differences in cardiac structure and function between black and white patients: Another step in the evaluation of cardiovascular risk in chronic kidn…

2017

medicine.medical_specialtyEuropean Continental Ancestry Group030232 urology & nephrologyMEDLINE030204 cardiovascular system & hematologyLeft ventricular hypertrophyWhite PeopleCohort Studies03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineCardiovascular DiseaseInternal MedicinemedicineHumansCardiac structureRenal Insufficiency ChronicFramingham Risk ScoreWhite (horse)business.industryRisk Factormedicine.diseaseCardiovascular DiseasesCardiologyOriginal ArticleCohort StudiebusinessCohort studyKidney diseaseHuman
researchProduct

Nephro-broncho-cutaneous Fistula

1989

medicine.medical_specialtyFistulaUrinary Fistulabusiness.industryUrologyCutaneous fistulaSkin DiseasesDermatologyRadiographyHumansMedicineFemaleKidney DiseasesBronchial FistulabusinessAgedBritish Journal of Urology
researchProduct

New loci associated with kidney function and chronic kidney disease

2010

Chronic kidney disease (CKD) is a significant public health problem, and recent genetic studies have identified common CKD susceptibility variants. The CKDGen consortium performed a meta-analysis of genome-wide association data in 67,093 individuals of European ancestry from 20 predominantly population-based studies in order to identify new susceptibility loci for reduced renal function as estimated by serum creatinine (eGFRcrea), serum cystatin c (eGFRcys) and CKD (eGFRcrea 60 ml/min/1.73 m 2; n = 5,807 individuals with CKD (cases)). Follow-up of the 23 new genome-wide-significant loci (P 5 × 10 8) in 22,982 replication samples identified 13 new loci affecting renal function and CKD (in or…

medicine.medical_specialtyGENOME-WIDE ASSOCIATION ; SERUM CREATININE ; PROTEIN ; GENE ; MUTATIONS ; VARIANTS ; POPULATION ; CANDIDATE ; HOMOLOG ; MEGALINPopulationRenal functionGenome-wide association studyBiologyKidneyurologic and male genital diseasesCohort Studieschemistry.chemical_compoundSDG 3 - Good Health and Well-beingRisk FactorsInternal medicineGenetic MarkermedicineGeneticsHumansCystatin CeducationCystatin C/geneticsddc:616Genetic Markers/geneticsCreatinineKidneyeducation.field_of_studyModels GeneticRisk Factorchronic kidney disease; loci; SNPCreatinine/bloodmedicine.diseaseDietEuropeKidney/*physiologyEndocrinologymedicine.anatomical_structurechemistryCystatin CRenal physiologyCreatininebiology.proteinKidney Failure ChronicKidney Failure Chronic/ethnology/*geneticsCohort StudieKidney diseaseHumanGenome-Wide Association StudyGlomerular Filtration Rate
researchProduct